Search

everythinglearnresearchcommunity

for

Search:↓

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Genetic variation in the androgen receptor gene mainly causes early-onset hair loss, with maternal inheritance playing a key role.

EGFR inhibitors often cause skin problems and other side effects, but these are usually reversible and can be managed to keep patients comfortable.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

Minoxidil boosts hair growth by targeting adenosine and possibly sulfonylurea receptor 2B.

The three estrogen receptor genes are highly expressed in zebrafish neuromasts during development.

E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.

The conclusion is that hair growth can be improved by activating hair cycles, changing the surrounding environment, healing wounds to create new hair follicles, and using stem cell technology.

Prostaglandin D2 blocks new hair growth after skin injury through the Gpr44 receptor.

Activating β-catenin in different skin stem cells causes various types of hair growth and skin tumors.

The vitamin D receptor is essential for skin stem cells to grow, move, and become different cell types needed for skin healing.

New compounds with carborane showed anti-androgen effects similar to flutamide.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

Mice skin has components that could help with hair growth and might be used for diabetes treatment.

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

Androgen receptor signaling causes early aging of cells important for hair growth by damaging their DNA.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

A certain genetic variant in the androgen receptor may predict the severity of COVID-19 in men.

Activating β-catenin in certain skin cells speeds up hair growth in mice.

Certain gene variations are not a major cause of male infertility in Nigerian men.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Blocking a specific receptor slows down hair loss in mice.

Male rats have androgen receptors in their liver, which are different from proteins that bind estrogen.

DHT stops hair regrowth in mice, similar to human hair loss.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.